Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive ACE Inhibitor and Beta-Blocker in Duchenne Muscular Dystrophy
DRKS00000115Phase 3Completed
- Sponsor
- Friedrich-Alexander University Erlangen-Nuremberg
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD), heart failure (HF) and left ventricular dysfunction comparing Metoprolol Succinate + enalapril with Placebo (2 arms). Started Nov 2009; status: completed.
02
Drugs
metoprololenalapril
03
Conditions
Duchenne muscular dystrophy (DMD)heart failure (HF)left ventricular dysfunction
Beyond the preview
Go deeper on DRKS00000115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000115.